A Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Blood Glucose Control
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03088475 |
|
Recruitment Status : Unknown
Verified March 2017 by Wang Wenru, National University, Singapore.
Recruitment status was: Not yet recruiting
First Posted : March 23, 2017
Last Update Posted : March 23, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Aim. To develop and compare a nurse-led smartphone-based self-management programme with an existing nurse-led diabetes service on health-related outcomes of type 2 diabetes patients with poor glycaemic control in Singapore.
Background. Over the past decades, Asia has emerged as the 'diabetes epicentre' in the world due to rapid economic development, urbanisation, and nutrition transition. There is an urgent need to develop more effective care management strategies in response to this rising diabetes epidemic.
Design. A randomised controlled trial with pre- and repeated post-tests control group design.
Methodology. A total of 128 type 2 diabetes patients with poor glycaemic control will be recruited from the diabetes clinic of a public acute hospital in Singapore through convenience sampling. Study participants will be randomly allocated either to the experimental group or the control group. Outcome measures will include the 10-item General Self-Efficacy Scale, 11-item Revised Summary of Diabetes Self-care Activities, and 19-item Diabetes-Dependent Quality of Life. Data will be collected at three time points: baseline, 3 months, and 6 months from the baseline.
Discussion. It is expected that this programme will be an alternative offered to diabetes patients to master their self-care management skills, in addition to the existing diabetes service provided in diabetes clinics in Singapore hospitals. Furthermore, the self-supporting and less resource-intensive nature of this programme, through the use of a smartphone application as the mode of intervention delivery, will greatly reduce nurses' direct contact time with patients and allow more time to be allocated to those who require more attention.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Type2 Diabetes Mellitus | Behavioral: nurse-led smartphone-based self-management programme Behavioral: exiting nurse-led diabetes service | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 128 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Other |
| Official Title: | A Randomised Controlled Trial on a Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Glycaemic Control |
| Estimated Study Start Date : | January 1, 2018 |
| Estimated Primary Completion Date : | June 30, 2019 |
| Estimated Study Completion Date : | December 30, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Experimental Group
A six-month nurse-led smartphone-based self-management programme (i.e. NSSMP) will be provided to the participants in the experimental group.
|
Behavioral: nurse-led smartphone-based self-management programme
The participants in the experimental group will undergo nurse-led smartphone-based self-management programme (NSSMP), a 6-month programme comprising an individual education session, and a newly developed smartphone App as a self-help education resource |
|
Active Comparator: Control Group
the patients in the control group will receive the exiting nurse-led diabetes service (i.e. NDS) provided by the hospital
|
Behavioral: exiting nurse-led diabetes service
the patients in the control group will receive the exiting nurse-led diabetes service (i.e. NDS) provided by the hospital |
- Self-efficacy: change is being assessed [ Time Frame: Change from baseline self-efficacy at 6 months ]Self-efficacy will be assessed using the General Self-efficacy Scale (GSS), a 10-item questionnaire of the unidimensional measure of one's competence to deal with the challenging events encountered in various life situations
- Diabetes self-care activities: change is being assessed [ Time Frame: Change from baseline diabetes self-care acitivities at 6 months ]Diabetes self-care activities will be measured using the 11-item Revised Summary of Diabetes Self-care Activities (RSDSCA)
- Health-related Quality of Life: change is being assessed [ Time Frame: Change from baseline health-related quality of life at 6 months ]Health-related Quality of Life will be measured using the 19-item Diabetes-Dependent Quality of Life (DDQoL)
- Acute Diabetes Complications: change is being assessed [ Time Frame: Change from baseline acute diabetes complications at 6 months ]the number of frequency of acute diabetes complications including hypoglycaemia, DKA and HHS will be collected
- HbA1c: change is being assessed [ Time Frame: Change from baseline HbA1c at 6 months ]HbA1c will be obtained from patient's medical record
- Smoking status: change is being assessed [ Time Frame: Change from baseline smoking status at 6 months ]Smoking status will reported by the participant.
- Alcohol consumption: change is being assessed [ Time Frame: Change from baseline alcohol consumption at 6 months ]Alcohol consumption will be reported by the participant
- Diabetes-related hospital admission [ Time Frame: at the 6-month of the study period ]number of diabetes-related hospital admission will be recorded
- Visits to the emergency [ Time Frame: at the 6-month of the study period ]number of diabetes-related emergency department visit will be recorded
- Unplanned medical consultation [ Time Frame: at the 6-month of the study period ]number of unplanned medical consultation due to diabetes problems will be recorded
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 21 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- have confirmed medical diagnosis of type 2 DM;
- are 21 years old and above;
- have blood test result of HbA1c > 8% in the most recent test indicating poor glycemic control;
- possess and able to use smart mobile phone (e.g. Samsung Galaxy, iPhone) in their daily lives; and
- are able to speak and read English or Chinese.
Exclusion Criteria:
- have suffered severe complications such as severe stroke, visual impairment, renal failure that interfere with self-care activities;
- have known history of major psychiatric illness;
- have reading and hearing difficulties.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03088475
| Contact: Wenru P Wang, PhD | 65 66011761 | nurww@nus.edu.sg |
| Principal Investigator: | Wenru P Wang, PhD | National University, Singapore |
| Responsible Party: | Wang Wenru, Principal Investigator, National University, Singapore |
| ClinicalTrials.gov Identifier: | NCT03088475 |
| Other Study ID Numbers: |
AcRFTier1FRCT1-2016APR-02 |
| First Posted: | March 23, 2017 Key Record Dates |
| Last Update Posted: | March 23, 2017 |
| Last Verified: | March 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |

